GEHC (GE HealthCare Technologies) Cash And Cash Equivalents : $3,550 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Cash And Cash Equivalents?

GE HealthCare Technologies's quarterly cash and cash equivalents declined from Mar. 2024 ($2,551.00 Mil) to Jun. 2024 ($1,997.00 Mil) but then increased from Jun. 2024 ($1,997.00 Mil) to Sep. 2024 ($3,550.00 Mil).

GE HealthCare Technologies's annual cash and cash equivalents increased from Dec. 2021 ($554.00 Mil) to Dec. 2022 ($1,440.00 Mil) and increased from Dec. 2022 ($1,440.00 Mil) to Dec. 2023 ($2,494.00 Mil).

GE HealthCare Technologies Cash And Cash Equivalents Historical Data

The historical data trend for GE HealthCare Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Cash And Cash Equivalents Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

994.00

554.00

1,440.00

2,494.00

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash And Cash Equivalents	Get a 7-Day Free Trial										2,408.00	2,494.00	2,551.00	1,997.00	3,550.00

GE HealthCare Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

GE HealthCare Technologies (NAS:GEHC) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

GE HealthCare Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

GEHC:Mexico L0T:Germany

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

Executives

Roland Rott	officer: CEO, Ultrasound	500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski	officer: Ch. Supply Chain & Serv. Ofc.	500 W MONROE, CHICAGO IL 60661
Thomas J. Westrick	officer: CEO, Patient Care Solutions	500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout	officer: Chief Technology Officer	500 W. MONROE STREET, CHICAGO IL 60661
Jan Makela	officer: CEO, Imaging	500 W. MONROE STREET, CHICAGO IL 60661
Frank R Jimenez	officer: GC & Corporate Secretary	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061
Kevin Michael O'neill	officer: CEO, PDx	500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro	officer: Chief Financial Officer	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Culp H Lawrence Jr	director	GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg	director	100 E. PRATT STREET, BALTIMORE MD 21202
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman	director	21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic	director	ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell	director	8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden	director	C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202